Full Text View
Tabular View
No Study Results Posted
Related Studies
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
This study has been completed.
Study NCT00159653.   Last updated on September 5, 2007.
Information provided by Pfizer
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glaucoma, Open-Angle
Ocular Hypertension
Additional conditions recognized in this trial
Glaucoma
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Vascular Diseases
Interventions listed in this trial
Xalacom
Xalatan
Timolol
Additional drug interventions recognized in this trial
Latanoprost
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Pfizer


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services